RITONAVIR (r), 25mg, tab.
STD
DORARITO2T-
Valid Article
Account code:
60000
HS Code:
300490
Last Updated on:
22/10/2024, 12:28:19
6.4.2.3 - Protease inhibitors
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J05AE03
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
RITONAVIR (r)
Therapeutic Action
Antiretroviral, protease inhibitor (PI)
Indications
Booster for protease inhibitors (atazanavir, darunavir, lopinavir, etc.) in HIV infection
Instructions for use
The 25 mg heatstable tablet (intended for paediatric use) replaces the 50 mg tablet and the oral solution.
Ritonavir should not be used alone but in combination with other protease inhibitors.
Fixed-dose combinations (FDC) are available:
- ATV 300mg / r 100mg, tab.
- LPV 40mg / r 10mg, granules, sachet
- LPV 100mg / r 25mg, tab.
- LPV 200mg / r 50mg, tab.
- DRV eq. 400mg base / r 50mg, tab.
May be used in addition to the FDC of lopinavir/ ritonavir for additional boosting and to decrease the drug interaction with rifampicin in children on TB treatment.
Storage
Below 25ºC